ACTAVIS LLC FDA Approval ANDA 206516

ANDA 206516

ACTAVIS LLC

FDA Drug Application

Application #206516

Application Sponsors

ANDA 206516ACTAVIS LLC

Marketing Status

Prescription001

Application Products

001POWDER;INTRAVENOUSEQ 50MG BASE/VIAL0LEVOLEUCOVORIN CALCIUMLEVOLEUCOVORIN CALCIUM

FDA Submissions

UNKNOWN; ORIG1AP2017-02-13STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

ACTAVIS LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206516
            [companyName] => ACTAVIS LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVOLEUCOVORIN CALCIUM","activeIngredients":"LEVOLEUCOVORIN CALCIUM","strength":"EQ 50MG BASE\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/13\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-02-13
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.